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ABSTRACT
Patients undergoing bariatric surgery are at increased risk of developing nutritional defi-
ciencies from the limited intake and absorption of different nutrients. Thus, a systematic 
review on PubMed and ISI Web of Science was conducted, including articles from Sep-
tember 1983 to April 2010, to identify literature regarding nutritional deficiencies follow-
ing bariatric surgery and how treatment is carried out. The keywords used individually 
or in combinations were: bariatric surgery, obesity, vitamin/mineral deficiencies, protein 
deficiency, nutrient absorption, and nutrient supplementation. The literature suggests 
the use of nutritional supplementation to prevent or treat nutritional deficiencies result-
ing from anatomical changes due to surgical techniques. The success of oral nutritional 
supplementation in correcting or preventing nutritional deficiencies depends on several 
factors. Thus, it is very important in clinical practice to understand how the nutrients can 
be administered. This review aims is to assist in better selecting the nutrients to ensure an 
appropriate nutrient replacement in patients undergoing bariatric surgery.
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Figure 1 – Roux-en-Y gastric bypass technique and its main 
metabolic changes. Smaller rectangles show the nutrients 
and/or hormone production (arrows indicating the main 
absorption sites and/or production site).
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INTRODUCTION
Currently, bariatric surgery is considered the most ef-
fective tool in severe obesity control and treatment. The 
surgery benefits include healing or marked improvement 
of chronic diseases, such as hypertension, diabetes and 
hyperlipidemia1. However, it must be noted that surgical 
treatment of obesity is not confined to surgery.
In vivo studies have demonstrated that some nutri-
tional deficiencies encompassing vitamin D2-4, vitamin A5,6 
and zinc are concomitantly present in obesity, possibly by 
playing important role in adiposity regulation or in appe-
tite regulation mechanisms. Thus, a careful planning for 
clinical-nutritional follow-up is essential. Both pre- and 
early and late postoperatory is extremely important for 
treatment success10. In this setting, the phrase “healthy 
weight loss” has been well applied.
The implications of surgical procedures on the pa-
tient’s nutritional status are specifically due to anatomical 
and physiological changes impairing absorption pathways 
and/or food intake. A good understanding of gastroin-
testinal tract absorption physiology is very important to 
understand potential nutritional deficiencies following 
surgery (Figure 1)10,11.
The main type of bariatric surgery currently performed 
is the Roux-en-Y gastric bypass (RYGB)12, a mixed surgical 
technique by restricting the gastric cavity size and hence 
the amount of food ingested and by reducing the bowel 
surface in contact with the food (dysabsorption).
The poor nutrient absorption is one of the explana-
tions for the weight loss reached by using dysabsorptive 
techniques, such as the biliopancreatic diversion with duo-
denal switch (BPD), with 25% of protein and 72% of fat 
no longer being absorbed13. Automatically, nutrients de-
pending on dietary fat to be absorbed, such as liposoluble 
vitamins and zinc, are more susceptible to malabsorption 
from this kind of procedure14.
Vitamins and minerals are essential factors and cofac-
tors in many biological processes regulating directly or 
indirectly the body weight (Table 1). The metabolic ben-
efits of these micronutrients in controlling the weight loss 
include regulation of appetite, hunger, nutrient absorp-
tion, metabolic rate, lipid and carbohydrate metabolism, 
the functions of thyroid and adrenal glands, energy store, 
glucose homeostasis, and neural activities among others. 
Thus, the “adequacy” of micronutrients is important not 
only for health maintenance, but also for achieving maxi-
mum success in maintaining long-term weight loss13.
The symptoms of micronutrient deficiency are usually 
nonspecific in subclinical levels, and the physical exam 
may not be reliable for an early diagnosis without a labo-
ratory confirmation. Thus, specific clinical signs are only 
noticeable in a developed phase of the deficiency15.
Considering the increasing number of bariatric sur-
geries currently performed and the presence of nutrition-
al deficiencies found in these patients, we will address in 
this review a few nutrition supplementation forms cur-
rently proposed in literature with the purpose of better 
selecting the nutrients and ensure the appropriate re-
placement of nutrients.
METHODOLOGY
A systematic review in several data bases, such as PubMed 
(US National Library of Medicine, Bethesda, MD) and ISI 
Web of Science (Science Citation Index Expanded) was 
conducted. The following keywords were used individu-
ally or in combinations: bariatric surgery, obesity, gastric 
bypass, dietary supplement, vitamin deficiencies, mineral 
deficiencies, and nutrient absorption. Sixty-eight articles, 
published between September 1983 and April 2010, were 
selected, including two meta-analysis and two internation-
al guidelines for clinical practice in bariatric surgery. Only 
two studies were not conducted in humans.
NUTRITIONAL SUPPLEMENTATION
Micronutrient deficiencies are the main changes that put 
the surgical procedure success at risk16. Prevention of vita-
min and mineral deficiencies requires long-term patient’s 
follow-up and understanding of the functions of these mi-
cronutrients in human body, in addition to the deficiency 
signs and symptoms. The long-term nutritional supple-
mentation, although so stressed as an important conduct, 
still represents a hindrance to success in surgical treatment 
of obesity17.
The regular use of a nutritional supplementation has 
been advocated when appropriately done: at least five 
times a week13. However, only 33% of patients comply with 
that recommendation, and 7.7% stop using the multivita-
mins/minerals two years after surgery18.
The replacement and incorporation of micronutrients 
from food into the body is the most appropriate way to 
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keep the body stores within the desirable level. However, 
a few factors warrant the nutritional supplementation in 
patients undergoing bariatric surgery (Table1). Therefore, 
the use of an appropriate multivitamin/mineral daily dose 
is a way to ensure the appropriate nutritional support of 
micronutrients for a good functioning of processes assist-
ing in body weight regulation13.
The concern with micronutrient bioavailability inu-
ences on the supplementation e cacy. Accordingly, it is 
important to consider the quantitative and qualitative 
composition of marketed supplements. When choosing a 
supplement, consider:
– pH (acid or alkaline): required gastrointestinal pH to 
solubilize the nutrient;
– qualitative composition of the supplement: aqueous 
solution, capsule, powder;
– dependence of gastrointestinal enzymes assisting in 
some micronutrient absorption;
– bowel integrity and absorption surface;
– administration route: oral, intramuscular or intrave-
nous, according to degree of nutritional deficiency;
– quantity and micronutrient type present in the com-
position.
With the advent of compounding pharmacies, it is pos-
sible to prepare vitamin and mineral formulations in sev-
eral combinations, using the desired dose and at times with 
a similar or lower cost than commercial standard multivi-
tamins. When opting for this form of supplementation, the 
clinician should be aware of the prescription form.
Other considerations are important when recommend-
ing multivitamins/minerals already marketed (Table 2). 
Usually folic acid and vitamin B12 are present in lower 
Table 1 – Bariatric surgery outcomes warranting nutritional supplementation
Surgical technique outcomes Nutritional implications
– Gastric capacity restraining – Lower calory and micronutrient intake and lower HCl production 
by the stomach
– Exclusion of stomach and bowel from the food transit – Reduced contact surface for absorption, limited production of 
factors required for nutrient absorption (e.g., intrinsic factor and 
digestive enzymes)
– Food intolerance – Exclusion of food containing sources of key nutrients for health 
Table 2 – Guidelines for choosing preventive nutritional 
supplementation following bariatric surgery
Supplement/characteristics Dose
Multivitamin/minerala 1 to 2 tablets/day
Folic acid > 400 mg
Iron (ferrous fumarate) > 18 mg
Formulated with zinc and selenium —
Adapted from AACE/TOS/ASMBS Bariatric Surgery Guidelines, 
2008.13. Recommendations for micronutrient deficiency prevention. 
aThe prevention should start on the first day after hospital discharge. 
Patients with pre- and postoperative nutritional deficiencies should 
be treated according to Table 3 for isolated supplementation.
amounts and the formulations contain moderate doses 
of folate (200 – 400 mcg) and low doses of vitamin B12 
(5-50 mcg). All patients undergoing BYGB and BPD should 
be supplemented with multivitamins/minerals as fully as 
possible, including liposoluble vitamins and minerals19.
It is important to remember that some nutrients re-
quire a specialized mixture to obtain maximum absorp-
tion. For instance, iron is better absorbed in an acid envi-
ronment and liposoluble vitamins require a lipid source. 
In addition, certain nutrients are preferentially absorbed 
at proximal bowel while others at the distal bowel, as dem-
onstrated in Figure 1. Thus, the kind or surgical procedure 
performed also inftuence the care in nutritional supple-
ment choice. In Roux-en-Y gastric bypass (RYGB), e.g., 
there is a prevalence of vitamin B12, iron, and folic acid de-
ficiencies14. On the other hand, following biliopancreatic 
diversion/duodenal swich (BPD/DS), only 28% of lipids 
ingested are absorbed20.
Starting multivitamin/mineral supplementation or iso-
late iron replacement has been recommended soon after 
hospital discharge13. However, some hospitals have already 
made such supplementation available in the early postop-
erative period (48 hours).
Isolate supplementation of vitamins and/or miner-
als is used in cases of nutritional deficiency diagnosis or 
when there is a purpose of reducing the interaction with 
other nutrients that could impair their absorption (Table 
3). In this case, the clinician and nutritionist determine 
whether a multivitamin/mineral supplementation  may 
remain or not concurrently with deficiency therapy. Be-
low we will report studied forms of supplementation after 
bariatric surgery. 
THIAMINE
Thiamine deficiency may occur acutely following any type 
of bariatric surgery in patients presenting with longstand-
ing vomiting and is associated with severe neurological 
symptoms that could even be irreversible21-23.ft
Thiamine deficiency following bariatric surgery has 
been treated together with other B complex vitamins and 
magnesium to achieve maximum thiamine absorption 
and appropriate neurological function24.
The first symptoms of neuropathy can often be re-
solved by oral supplementation with thiamine 20-30 mg/
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Table 3 – Guidelines for isolated nutritional supplementation
Supplement Dose
Thiamine 20-30 mg/day
50-100 mg/day (intravenously or 
intramuscularly)
100 mg/day (WKS)
Vitamin B12 ≥ 350 mg/day (oral prevention)
500 mg/day (oral treatment)
or 1,000 mg/mol (IM)
or 3,000 mg/ six-monthly (IM)
or 500 mg weekly (nasally or 
sublingually)
Calcium citrate 1,500 mg/day (AGB)
1,500 to 2,000 mg/day (RYGB)
1,800 to 2,500 mg/day (BPD/DS)
Elemental iron  40 to 65 mg/day (oral prevention)
300 mg/day (oral treatment)
Liposoluble vitamins 10,000 to 100,000 IU / day of 
vitamin A
> 2,000 IU of vitamin D 
(cholecalciferol)
100 to 400 IU/day
Wernicke-Korsakoff syndrome (WKS), intramuscular (IM) route; AGB, 
adjustable gastric band (AGB); Roux-en-Y gastric bypass (RYGB); 
biliopancreatic diversion/duodenal switch ( BPD/DS).
day  until symptoms subside. When there are signs of a 
more advanced neuropathy or in the presence of persist-
ing vomiting, 50-100 mg/day intravenously or intramus-
cularly may be required.
In the presence of the Wernicke-Korsakoff syndrome, a 
supplementation above 100 mg/day is required25. This syn-
drome is characterized by signs such as ophthalmolplegia 
(lateral rectus muscle and conjugate gaze palsy or weak-
ness), ataxia (ambulation or posture impairment and slow 
gait), and mental and conscience disorders.
Most common risk factors associated with thiamine 
deficiency are: weight loss percentage, gastric symptoms 
persistence (nausea and vomiting), non-adherence to nu-
tritional follow-up, the reduction of albuminandtransfer-
rin, the presence of jejunoileal bypass26. Many reported 
cases are related to prolonged vomiting, starvation and, 
more often, alcoholism26-28.
VITAMIN B12
Vitamin B12 deficiency has been often reported following 
RYGB, with its incidence varying between 12% and 75%29-32. 
Low vitamin B12 levels can be seen at six months postopera-
tively, but they occur mostly at one year or more when liver 
storages is found to be depleted32. High prevalence of such a 
deficiency has also been reported ten years after the surgery33.
Regarding vitamin B12 absorption,  it is important to 
remember that initially it needs to be liberated from the 
food source (particularly red meat).
The releasing is facilitated by the presence of gastric 
acid. Free vitamin B12 then binds to R-protein in the stom-
ach and is cleaved in the duodenum to bind intrinsic factor 
(IF). The B12-IF complex circulates intact through the gas-
trointestinal tract to its absorption site (ileum). Marcuard 
et al.34 observed low IF levels in 53% of patients with vita-
min deficiency after RYGB.
The frequent absence of symptoms in the presence 
of vitamin B12 deficiency and the irreversible neurologic 
damage risk13 require a careful decision about supple-
menting or not the vitamin in a preventive manner. Vi-
tamin B12 is present in the nutritional composition of 
most multivitamins commercially available, however, the 
amounts vary widely.
Vitamina B12 deficiency is usually defined as levels be-
low 200 pg/mL. However, about 50% of patients with clear 
deficiency signs and symptoms show normal levels35. Re-
garding prevention, a 350 mcg/day oral dose could prevent 
deficiency in 95% of patients32. and a 500 a 1,000 mcg/day 
dose has been used to treat the deficiency11,18.
Currently, B12 supplementation is also commercially 
available as a spray to be applied sublingually. This kind of 
supplementation is presented as nanoparticles to increase 
vitamin absorption and bioavailability. Although vitamin 
B12 deficiency occurs only after a few months from bariat-
ric surgery, a good clinical practice has been preventively 
administering 1000 mg vitamin B12 parenterally over the 
preoperative period36.
FOLIC ACID
Folic acid deficiency has been observed mainly after 
RYGB. It can manifest as macrocytic anemia, leukopenia, 
thrombocytopenia, glossitis, or megaloblastic bone mar-
row. Most of the time, folic acid deficiency occurs after 
bariatric surgery due to reduced intake and not resulting 
from poor absorption37.
Although less frequent than vitamin B12 deficiency, low 
levels of folic acid have been reported between 6% and 
65% of patients undergoing RYGB29,38,39 and can easily be 
treated by oral supplementation37.
Folic acid absorption occurs preferably in the duode-
num, but it can also occur along the entire small bowel 
length due to a physiological adaptation after surgery. Vi-
tamin B12 is required to convert methyl-tetrahydrofolic 
acid (inactive) into tetrahydrofolic acid (active). There-
fore, vitamin B12 deficiency can result from folic acid de-
ficiency30,37.
In general, folic acid deficiency is treated with 
1,000 mg/day of folic acid (orally) for one to two months40 
and can be prevented with a supplement containing 200% 
the recommended daily value (800 mg/day). This level can 
also benefit the fetus in case of an unaware pregnancy in 
the post-operatory phase. A supplementation higher than 
1,000 mg/day can “mask” a vitamin B12 deficiency diag-
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nosis, thereof the importance of monitoring the vitamin 
blood levels mostly when high folic acid dose supplemen-
tation is adopted13.
IRON
Anemia can affect two-thirds of patients undergoing bar-
iatric surgery, usually caused by iron deficiency. In patients 
undergoing RYGB, the deficiency ranges from 20% to 
49%32,37,40. Among superobese patients, anemia is reported 
in 35-74% and iron deficiency can reach 52% in late post-
operative period41.
In patients undergoing bariatric surgery, the amount of 
daily intake of elemental iron (ferrous sulfate or ferrous fu-
marate) should reach 40 to 100 mg/day although the long-
term prophylactic treatment e cacy is unknown32.
The amount of elemental iron present in most com-
mercial multivitamins is usually small (10 to 20 mg per 
tablet), which is considered insu cient to prevent iron de-
ficiency in patients undergoing RYGB. The current recom-
mendations include administering 40 to 65 mg elemental 
iron daily (200-400 mg ferrous sulphate). In women of 
childbearing age, the recommendations increase to 100 mg 
elemental iron daily (400 to 800 mg ferrous sulphate)10,35,42. 
Thus, the anemia clinical course, laboratory value changes, 
age, gender, and reproductive considerations should be 
analyzed.
On the other hand, iron deficiency treatment requires 
supplementation up to 300 mg/day, usually three to four 
tablets containing 50 to 65 mg elemental iron13. When 
treatment fails or in the presence of severe anemia, intra-
venous doses of an iron hydroxide-saccharose complex are 
required (20 mg elemental iron per mL)43,44.
Currently, commercially available multivitamins, 
mainly in the United States, lack iron in their composi-
tion  to ensure that this replacement must be performed 
in isolation and at different times of day. It is important to 
considerer the different absorption characteristics of vari-
ous iron supplementation types available in the market:
Ferrous fumarate: 33% elemental iron, usually well tol-
erated by patients and showing good mineral absorption.
Ferrous sulphate: only 20% elemental iron and show-
ing larger gastrointestinal effects.
Ferronyl: 98% elemental iron. Elemental iron with re-
duced particles.
Ideally, the iron supplement should be accompanied 
by vitamin C and fruto-oligosaccharides to prevent con-
stipation, improve intestinal ora, and provide better ab-
sorption of the mineral. Other important consideration 
is related to iron interaction with other elements, such as 
calcium and phytate45, and it is important to supplement it 
alone and in the fasting state. In addition, copper deficien-
cy can cause anemia, with some authors recommending 
supplementation with 900 mg/day copper or an additional 
supplementation with 50 to 200 mg/day according to the 
surgical technique used.
CALCIUM AND VITAMIN D
Calcium and vitamin D supplementation has been recom-
mended in most weight loss therapies in order to prevent 
bone reabsorptioin46. The preferable way of supplementing 
has been widely discussed in clinical practice. In the pres-
ence of a less acid environment, such as the small stomach 
after a bariatric surgery, calcium carbonate absorption be-
comes impaired47.
A meta-analysis suggests calcium citrate is more bio-
available than calcium carbonate, around 22% to 27%48. In 
patients undergoing RYGB, calcium citrate (500 mg/day 
associated with 125 IU vitamin D3-cholecalciferol), dem-
onstrated a greater increase in calcium serum levels and 
greater reduction in parathyroid hormone (PTH) than the 
same amounts of calcium carbonate supplemented49. PTH 
is the main regulator of calcium homeostasis in mam-
mals and also acts in forming 1,25 (OH)2D, a metabolite 
responsible for almost all actions of vitamin D. High cal-
cium levels inhibit PTH release, while low calcium levels 
leads to increased PTH release by parathyroid glads50. Fur-
thermore, calcium absorption occurs in the bowel under 
vitamin D inftuence51.
A vitamin D deficiency after bariatric surgery has been 
reported among 50-80% of the cases14,52-54. Some studies 
demonstrated that over 50% of patients that show vita-
min D deficiency after bariatric surgery used multivita-
mins containing 400-800 IU of vitamin D per day.14,52,53 
Other studies found a postoperative supplementation with 
1,200 mg/day calcium carbonate and 400 to 800 IU vita-
min D3 (cholecalciferol) present in multivitamins/miner-
als was not enough to prevent high levels of PTH and bone 
reabsorption46,55,56. Thus, over 50% of patients undergoing 
RYGB showed calcium deficiency in the presence of that 
supplementation pattern57. However, increasing calcium 
citrate doses from 1000 mg to 1700/day (including 400 IU 
of vitamin D) could reduce bone loss even in the presence 
or weight loss58. Th us, the current calcium supplementa-
tion recommendation in the postoperative phase varies 
according to the surgical technique applied.
Regarding vitamin D, when a deficiency is present pre-
operatively, the supplementation with 5000 IU of oral cho-
lecalciferol once a week for eight weeks is recommended59. 
Postoperatively, the same dose was not enough to treat vi-
tamin D deficiency60. Thus, there is no appropriate dose 
for all patients undergoing bariatric surgery yet. However, 
doses as high as 5000 IU/day have been found safe and po-
tentially required to treat the secondary hyperparathyroid-
ism present in some patients. We suggest it is appropriate 
to start supplementation with 2000 IU/day of vitamin D 
postoperatively, preferably as vitamin D3 (cholecalciferol). 
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Attention should be given to other factors such as patients 
taking anticonvulsants, glucocorticoids, heparin, or chole-
styramine with a higher risk for bone disease.
VITAMIN A AND VITAMIN E
Yearly monitoring of liposoluble nutrients should be ob-
tained after disabsorptive procedures. The recommen-
dation of 50,000 IU of vitamin A every other week has 
been suggested to correct most deficiency cases19. In their 
study, Sugerman et al.61 reported that supplementation 
of 10,000 IU of vitamin A was su cient to prevent any 
deficiency. Actually, the doses used in treating vitamin 
A deficiency vary according to the signs and symptoms 
presented. In the absence of corneal changes, the supple-
mentation with 10,000 to 25,000 IU/day is recommended 
until there is clinical improvement of symptoms (nor-
mally between 1 and 2 weeks); in the presence of corneal 
changes, 50,000 to 100,000 IU/day (intramuscularly) for 
2 weeks are required13. It is also important to assess iron 
and copper deficiency, as it can hamper the resolution of 
vitamin A deficiency.
Regarding vitamin E, there is no therapeutic recom-
mendation considered ideal or clearly defined. The poten-
tial antioxidant effects of vitamin E can be achieved with 
supplementation of 100 to 400 IU/day13.
PROTEINS
Protein deficiency is the most often reported among 
macronutrientes. It is observed mainly after disabsorptive 
or mixed surgical techniques (DBP/DS and RYGB)13. Only 
57% of the ingested protein is estimated to be absorbed 
after bowel bypass10,62.
The hypoalbuminemia (albumin < 3.5 g/dL) after 
RYGB may vary from 13% two years after the surgery63 to 
27.9% after ten years33 or it might even be absent in the 
first months64-66.
Some experts recommend 70 g/day of protein during 
caloric restriction to lose weight67. However, many bariat-
ric surgery programs recommend 60 to 80 g/day of protein 
or 1.0 to 1.5 g/kg of optimum body weight, although the 
exact requirements have not been defined yet. The patient 
should be instructed to use high biological value powder 
protein supplements 48 hours after the surgery.
Meat, poultry, fish, eggs, milk and dairy should be en-
couraged still in the first postoperative months according 
to the diet evolution protocol. Protein intake should be 
periodically evaluated in each nutritional visit. In the pres-
ence of clinical or subclinical protein deficiency, even in 
the absence of vomiting or food intolerance, the patients 
must be treated with hyperproteic diet68.
Protein modules are widely available on the market. 
However, factors such as %avor, texture, solubilization, ab-
sorption, and cost are considered important when choos-
ing the supplements. The amine acid profile should be giv-
en priority when the supplement is the only protein source 
in the diet. Whey protein can be an excellent choice, since 
it has high level of branched-chain amine acids, which are 
important to prevent muscle tissue degradation, remain 
stable in the stomach, are rapidly digested, and lactose-
free. Currently, there is a hydrolyzed whey protein product 
which reduces allergenicity and improves absorption.
CONCLUSION
There are no absolutely appropriate recommendations to 
prevent or treat most nutritional deficiencies after bariatric 
surgery yet; however, it is clear that preventive supplemen-
tation has been increasingly important in this setting.
Many factors are involved in causing such deficien-
cies. Even before any surgical intervention, obesity can 
be associated with subclinical nutritional deficiencies that 
could be aggravated after the anatomical and physiologi-
cal changes caused in gastrointestinal tract. In addition, 
there is a limitation and/or change in the dietary intake.  
Therefore, nutritional supplementation becomes a neces-
sary alternative therapy, contributing to weight loss in a 
healthy manner and, in most cases, it should be evaluated 
individually.
The preventive use of multivitamins/minerals should 
compound the care protocol in all patients undergoing 
bariatric surgery, mainly in those undergoing techniques 
involving a certain degree of dysabsorption. The treatment 
of these patients’ nutritional deficiencies should consider 
micronutrient megadoses due to lower bioavailability re-
sulting from physiological changes provided by the surgi-
cal techniques. Further studies are required to establish 
an effective dose to treat nutritional deficiencies following 
bariatric surgery.
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